Cita APA

WOLFORD, J. E., BAI, J., MOORE, K. N., KRISTELEIT, R., MONK, B. J., & TEWARI, K. S. (2020). COST-EFFECTIVENESS OF NIRAPARIB, RUCAPARIB, AND OLAPARIB FOR TREATMENT OF PLATINUM-RESISTANT, RECURRENT OVARIAN CARCINOMA. Gynecol Oncol.

Chicago Style Citation

WOLFORD, JULIET E., JIARU BAI, KATHLEEN N. MOORE, REBECCA KRISTELEIT, BRADLEY J. MONK, i KRISHNANSU S. TEWARI. "COST-EFFECTIVENESS OF NIRAPARIB, RUCAPARIB, AND OLAPARIB FOR TREATMENT OF PLATINUM-RESISTANT, RECURRENT OVARIAN CARCINOMA." Gynecol Oncol 2020.

Cita MLA

WOLFORD, JULIET E., et al. "COST-EFFECTIVENESS OF NIRAPARIB, RUCAPARIB, AND OLAPARIB FOR TREATMENT OF PLATINUM-RESISTANT, RECURRENT OVARIAN CARCINOMA." Gynecol Oncol 2020.